Vimarsana
Biggest News Aggregation in the World

Shane Kovacs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shane Kovacs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shane Kovacs Today - Breaking & Trending Today

Al Park & Unknown Legends with Candice Milner and Shane Kovacs - A Rolling Stone, Christchurch - Vimarsana News

Al Park & Unknown Legends with Candice Milner and Shane Kovacs - A Rolling Stone, Christchurch

Al Park & Unknown Legends with Candice Milner and Shane Kovacs, A Rolling Stone, Christchurch Fri, 25 August - Gigs and events at Undertheradar.co.nz.

Olema Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update - Vimarsana News

Olema Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Initiation of OPERA-01 pivotal Phase 3 monotherapy clinical trial on track; expecting to enroll first patient in fourth quarterNew clinical data for palazestrant to be presented in the fourth quarter...

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, Aug. 02, 2023 -- Olema Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for...

Olema Oncology to Present at the Canaccord Genuity 43rd - Vimarsana News

Olema Oncology to Present at the Canaccord Genuity 43rd

SAN FRANCISCO, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage...

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, July 05, 2023 -- Olema Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for...